Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies
Between September 2017 and February 2018, influenza A(H1N1)pdm09, A(H3N2) and B viruses (mainly B/Yamagata, not included in 2017/18 trivalent vaccines) co-circulated in Europe. Interim results from five European studies indicate that, in all age groups, 2017/18 influenza vaccine effectiveness was 25...
| Glavni autori: | , , , , , , , , , , |
|---|---|
| Daljnji autori: | |
| Format: | Journal article |
| Jezik: | English |
| Izdano: |
European Centre for Disease Prevention and Control
2018
|